GPA
Guerra Pan Advisors Portfolio holdings
AUM
$152M
This Quarter Return
+5.85%
1 Year Return
+22.34%
3 Year Return
+110.17%
5 Year Return
–
10 Year Return
–
AUM
$138M
AUM Growth
+$138M
(+11%)
Cap. Flow
+$13.5M
Cap. Flow
% of AUM
9.75%
Top 10 Holdings %
Top 10 Hldgs %
38.19%
Holding
115
New
9
Increased
30
Reduced
11
Closed
3
Top Buys
| 1 |
Schwab U.S Small- Cap ETF
SCHA
|
$3.47M |
| 2 |
Schwab US Large-Cap Growth ETF
SCHG
|
$2.88M |
| 3 |
Arista Networks
ANET
|
$1.49M |
| 4 |
Allstate
ALL
|
$651K |
| 5 |
First Trust RBA American Industrial Renaissance ETF
AIRR
|
$549K |
Top Sells
| 1 |
Novo Nordisk
NVO
|
$226K |
| 2 |
GXO Logistics
GXO
|
$205K |
| 3 |
iShares Global Clean Energy ETF
ICLN
|
$178K |
| 4 |
iShares US Medical Devices ETF
IHI
|
$68.8K |
| 5 |
Walker & Dunlop
WD
|
$46.4K |
Sector Composition
| 1 | Technology | 33.86% |
| 2 | Industrials | 9.81% |
| 3 | Financials | 8.82% |
| 4 | Communication Services | 8.02% |
| 5 | Healthcare | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Vanguard Total Stock Market ETF
VTI
$522B
| $232K | 0.17% |
800
| – | – |
|
102
Booking.com
BKNG
$178B
| $229K | 0.17% |
+46
| New | +$229K |
|
103
Oracle
ORCL
$633B
| $224K | 0.16% |
1,342
| – | – |
|
104
Blackrock
BLK
$173B
| $222K | 0.16% |
217
| – | – |
|
105
Regions Financial
RF
$24B
| $222K | 0.16% |
9,435
| – | – |
|
106
Nike
NKE
$110B
| $219K | 0.16% |
2,893
| – | – |
|
107
iShares Core MSCI EAFE ETF
IEFA
$148B
| $215K | 0.16% |
3,066
| – | – |
|
108
Ametek
AME
$42.7B
| $215K | 0.16% |
1,192
| – | – |
|
109
Electronic Arts
EA
$42.9B
| $212K | 0.15% |
1,450
| – | – |
|
|
XYZ
110
Block, Inc.
XYZ
$46.5B
| $211K | 0.15% |
+2,486
| New | +$211K |
|
111
Monster Beverage
MNST
$61.2B
| $208K | 0.15% |
3,960
| – | – |
|
112
Research Solutions
RSSS
$103M
| $41.7K | 0.03% |
+10,045
| New | +$41.7K |
|
|
113
GXO Logistics
GXO
$5.87B
| – | – |
-3,936
| Closed | -$205K |
|
|
114
iShares Global Clean Energy ETF
ICLN
$1.53B
| – | – |
-12,090
| Closed | -$178K |
|
|
115
Novo Nordisk
NVO
$251B
| – | – |
-1,897
| Closed | -$226K |
|